Antiviral Library. HBV Subset. Focus on non-nucleoside compounds
|
|
- Louise Allison
- 6 years ago
- Views:
Transcription
1 Antiviral Library BV ubset ocus on non-nucleoside compounds YAI, eb, 2015
2 Isosteric transformations eference Compounds examples W BV replication inhibition in immortalized murine hepatocyte (AML12)-derived stable cell line (AML12BV10) and liver ep DE19 cells (EC 50 < 1 M) in MTT assays. Baruch Blumberg Institute Me high diversity :C,, W spiro analogues BV replication inhibition in human hepatoma epg and epg2.117 cells (EC 50 <0.005 and M, respectively). It showed no cytotoxicity against epg2 cells (CC 50 >100 M upon 4 days incubation), in resazurin assays. Janssen &D Ireland C (2014) BV DA replication inhibition (98% at 500 nm) in human hepatoma epg cells in a qpc-based assay. EC Pharm W BV replication inhibition in human hepatoma epg (EC 50 < M) and epg2.117 (EC 50 = M) cells in in vitro assays without cytotoxicity against epg2 cells (CC 50 > 100 M) in resazurin assays Janssen &D Ireland Compound extracted from Lllicium henryi C (2014) everse transcriptase inhibitors inhibit IV-1 reverse transcriptase BV with an IC 50 =0.41 M (in human liver epg cancer cell) Peking University antiviral activity against BsAg and BeAg antigens (IC 50 = 0.43 and 0.5 M; in ELIA assays) and it also showed significant cytotoxicity (TC 50 = 3.28 M; using MTT method) in human hepatoma ep G cells with therapeutic index values of 7.6 and 6.6, respectively. Zhengzhou University C (2013) W :, BV replication inhibition EC 50 = 0.21 and 0.62 M, in epg and epg2.117 cells, respectively Antivir es 2014, 107: 6 BM601, a novel inhibitor of BV W C (2014) W significant antiviral activity against BsAg, BeAg antigens and inhibited BV DA replication (IC 50 =121.49, and mcm, respectively) in human hepatoma ep G cells without showing any significant cytotoxicity (CC50 = mcm) in MTT assays. Kunming Institute of Botany activity against human hepatoma ep G (stably transfected with BV genome) and ep G2.117 (stably inducible BV producing cell line) cells (EC 50 = and M, respectively). Janssen &D Ireland Me + W sanguinarine derivatives C (2014)
3 University of Maryland Bioorg Med Chem Lett 2005, 15(24): 5397 U compound inhibited BV-DA (IC 50 =5.4 M and CC 50 >100 M) U Toll-like receptor TL7 ligand that stimulated I-alpha production in human peripheral blood mononuclear cells (MEC = 0.03 M). eported to be useful for the treatment of BV al these compounds dose-dependently inhibit activity of BV polymerase (by 42% at 1 mcg/ml) and also CV A-dependent A-polymerase (5B, by 75% at 10 mcg/ml) in vitro W Gilead ciences W W (C)n antiviral activity in lymphoid MT2 cells infected with 92T599-MT2 IV-1 strain with and 80.45% inhibition at 1 and 0.1 M, respectively, and IC 50 values of and M, in p24 estimation assays. It also showed cell viabilities of and 89.93% at 1 and 0.1 mcm, respectively, against MT2 cells (CC 50 >1 M), in MTT cytotoxicity assays Bioorg Med Chem 2010, 18(14): 5048 n:1-3 W U CCC-0975, dose-dependently reduced cccda (10, 20 and 70% reduction at 1, 3 and 10 mcm, respectively) and DP-rcDA levels in epde19 cells. compound inhibited BV proliferation in epg2 cellular assays (EC 50 =0.01 M). IC 50 <1.1 µm and I>90.9 ch Pharm 2011, 344(2): 78 U Enanta Pharmaceuticals, Inc. W compound inhibited BV replication in human hepatoma cells with respective EC 50 and EC 90 values of 0.6 M and 3.4 M. 42nd Intersci Conf Antimicrob Agents Chemother (ICAAC) (eptember 27-30, an Diego) 2002, Abst C-04522, inhibited BV DA replication in epg cells with IC 50 and CC 50 values of 1.46 and M (I=151.06) respectively, in MTT assays C (2012) EC 50 =4 M,BV-transfected human ep G2 cells C (2012) J Med Chem 2011, 54(16): 5660
4 Topological analogues ChemDiv Compounds (examples) W C G J template W K G T T Et 2 Et Et C (2014) D D E C C (2014) K K C
5 Topological analogues ChemDiv Compounds (examples) template Me Antivir es 2014, 107: 6 W W K K K G P P V V V G J Me D
6 Topological analogues ChemDiv Compounds (examples) template Br D G Br C Me T D
GPCR Library. ChemDiv Inc. 2015
GPC Library ChemDiv Inc. 2015 Knowledge Mining ources 2 PubChem Database Thomson Integrity ciinder ChEMBL Pocketom BindingDB Protein Data Bank MAD cientific publication & Patents (2010-2015) Knowledge
More informationHepatitis B Antiviral Drug Development Multi-Marker Screening Assay
Hepatitis B Antiviral Drug Development Multi-Marker Screening Assay Background ImQuest BioSciences has developed and qualified a single-plate method to expedite the screening of antiviral agents against
More informationSUPPLEMENTARY FIGURES AND TABLES
SUPPLEMENTARY FIGURES AND TABLES Supplementary Figure S1: CaSR expression in neuroblastoma models. A. Proteins were isolated from three neuroblastoma cell lines and from the liver metastasis of a MYCN-non
More informationNew developments in Non-Nucleoside Reverse Transcriptase Inhibitors(NNRTIs); from TIBO to Rilpivirine (TMC278)
ew developments in on-ucleoside Reverse Transcriptase Inhibitors(RTIs); from TIBO to Rilpivirine (TMC278) Jan Heeres and Paul J. Lewi Formerly Center for Molecular Design, Janssen Pharmaceutica V, Vosselaar
More informationDevelopment of Small Molecule Inhibitors of the Lethal Factor in Anthrax. Brian Englund Michigan State University September 13, 2006
Development of mall Molecule Inhibitors of the Lethal Factor in Anthrax Brian Englund Michigan tate University eptember 13, 2006 Introduction Proteolysis Mechanism Anthrax Inhibitors Panchal and Bavari
More informationDiscovery and Development of SARS-CoV 3CL Protease Inhibitors
Discovery and Development of SARS-CoV 3CL Protease Inhibitors Amy K. Patick, Ph.D. Group Director, Head of Virology Pfizer Global Research and Development La Jolla Laboratories http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5212a1.htm
More informationPREDICTING SUSCEPTIBILITY AND RESISTANCE FOR HEPATITIS B VIRUS CAPSID ASSEMBLY EFFECTORS
PREDICTING SUSCEPTIBILITY AND RESISTANCE FOR HEPATITIS B VIRUS CAPSID ASSEMBLY EFFECTORS BRYAN D. COX, PH.D. EMORY UNIVERSITY, DEPARTMENT OF PEDIATRICS LABORATORY OF BIOCHEMICAL PHARMACOLOGY EMORY CENTER
More informationEfficient Liver Targeting and Uptake by Novel Tenofovir Prodrug, CMX157, For the Treatment of Hepatitis B
Efficient Liver Targeting and Uptake by Novel Tenofovir Prodrug, CMX157, For the Treatment of Hepatitis B R Rush 1, J Greytok 2, T Matkovits 2, R Driz 2, JZ Sullivan-Bólyai 2, and D Standring 3 1 Allon
More informationViral hepatitis. The word hepatitis means inflammation of the liver. There are five main types of viral hepatitis: A, B, C, D, E
Viral hepatitis The word hepatitis means inflammation of the liver There are five main types of viral hepatitis: A, B, C, D, E Hepatitis A and E are typically caused by ingestion of contaminated food or
More informationSERUM HBV-RNA LEVELS DECLINE SIGNIFICANTLY IN CHRONIC HEPATITIS B PATIENTS DOSED WITH THE NUCLEIC-ACID POLYMER REP 2139-Ca
SERUM HBV-RNA LEVELS DECLINE SIGNIFICANTLY IN CHRONIC HEPATITIS B PATIENTS DOSED WITH THE NUCLEIC-ACID POLYMER REP 2139-Ca Louis Jansen 1,2, Andrew Vaillant 3, Karel van Dort 1, Femke Stelma 1,2, Neeltje
More informationANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1999, p Vol. 43, No. 8. Copyright 1999, American Society for Microbiology. All Rights Reserved.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 1999, p. 2017 2026 Vol. 43, No. 8 0066-4804/99/$04.00 0 Copyright 1999, American Society for Microbiology. All Rights Reserved. Use of the Hepatitis B Virus
More informationApplication of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients
Application of the KeratinoSens Assay for Prediction of Dermal Sensitization Hazard for Botanical Cosmetic Ingredients D. Gan 1, K. Norman 2, N. Barnes 2, H. Raabe 2, C. Gomez 1, and J. Harbell 1 1 Mary
More informationHCV Resistance Associated variants: impact on chronic hepatitis C treatment
HCV Resistance Associated variants: impact on chronic hepatitis C treatment Dr. Stéphane Chevaliez Associate Professor of Medicine at the University of Paris-Est. History of Resistance in HCV Concern Only
More informationHBV : Structure. HBx protein Transcription activator
Hepatitis B Virus 1 Hepatitis B Virus 2 Properties of HBV a member of the hepadnavirus group Enveloped, partially double-stranded DNA viruses, smallest DNA virus Replication involves a reverse transcriptase
More informationBiological Activities for Extracts of Mullaca (Physalis angulata)
Biological Activities for Extracts of Mullaca (Physalis angulata) IN VIVO RESEARCH Antitumor ETOH(95%)Ext IP Mouse 75 mg/kg Leukemia -P388 K07329 Leaf Not Stated Antitumor Fraction: Physalin F IP Mice
More informationLentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression.
Supplementary Figure 1 Lentiviral Delivery of Combinatorial mirna Expression Constructs Provides Efficient Target Gene Repression. a, Design for lentiviral combinatorial mirna expression and sensor constructs.
More informationTargeting RNA-Protein interactions within. the HIV-1 lifecycle.
SUPPORTING INFORMATION for Targeting RNA-Protein interactions within the HIV-1 lifecycle. Neil M. Bell, 1,2 Anne L Hernault, 2 Pierre Murat, 1 James E. Richards, 2 Andrew M.L. Lever 2 & Shankar Balasubramanian
More informationTherapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome
30 1, 1, 2, 3 1. ( ), 201508; 2., 200040; 3., 200032 : ( AIDS) ( HIV) 20 90,,,,,, AIDS, CD4 + T ( CTL), HIV, : ; ; Therapeutic strategies for immune reconstitution in acquired immunodeficiency syndrome
More informationSulfamoylbenzamide Derivatives Inhibit the Assembly of Hepatitis B Virus Nucleocapsids. Timothy M. Block 1,2 and Ju-Tao Guo 1*
JVI Accepts, published online ahead of print on 10 April 2013 J. Virol. doi:10.1128/jvi.00582-13 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 Sulfamoylbenzamide Derivatives
More informationNuevos fármacosf. Pere Domingo Malalties Infeccioses Hospital de la Santa Creu i Sant Pau Barcelona
Nuevos fármacosf Pere Domingo Malalties Infeccioses Hospital de la Santa Creu i Sant Pau Barcelona pdomingo@santpau.cat Fármaco Compañí ñía Familia Nº abstract GS-7340 Gilead ITIAN 152LB GSK 2248761 GSK
More informationIon-containing Poly(aminophosphonate)- based Nanocarriers for Simultaneous Magnetic Resonance Imaging and Drug Delivery
Polymers in Medicine and Biology October, 2013 Ion-containing Poly(aminophosphonate)- based Nanocarriers for Simultaneous Magnetic Resonance Imaging and Drug Delivery Nikorn Pothayee and A. P. Koretsky,
More informationJournal of Chemical and Pharmaceutical Research, 2018, 10(2): Research Article
Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research, 2018, 10(2):98-102 Research Article ISSN : 0975-7384 CODEN(USA) : JCPRC5 In vitro Anticancer Activity of Pyrazole Fused Triazole
More informationBasics of hepatitis B diagnostics. Dr Emma Page MRCP MD(Res) Locum Consultant Sexual Health & Virology
Basics of hepatitis B diagnostics Dr Emma Page MRCP MD(Res) Locum Consultant Sexual Health & Virology Basics of hepatitis B diagnostics Background Epidemiology Morphology Life-cycle Diagnostic markers
More informationSupporting Information
Supporting Information A Systemic Study on the Biogenic Pathways of Yezo otogirins: Total Synthesis and Antitumor Activities of (±)-Yezo otogirin C and its Structural Analogues Wei Yang, Jingming Cao,
More informationSupporting Information
Supporting Information Natural small molecule FMHM inhibits lipopolysaccharide-induced inflammatory response by promoting TRAF6 degradation via K48-linked polyubiquitination Ke-Wu Zeng 1, Li-Xi Liao 1,
More informationForward Looking Statements
Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created
More informationComparison of Anti-Hepatitis B Virus Activities of Lamivudine and Clevudine by a Quantitative Assay
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Jan. 2003, p. 324 336 Vol. 47, No. 1 0066-4804/03/$08.00 0 DOI: 10.1128/AAC.47.1.324 336.2003 Copyright 2003, American Society for Microbiology. All Rights Reserved.
More informationAntiviral Chemistry & Chemotherapy 2014; 23: (doi: /IMP2679)
Antiviral Chemistry & Chemotherapy 2014; 23:231 235 (doi: 10.3851/IMP2679 Short communication Myristoylated derivatives of 2 3 -didehydro- 2 3 -dideoxythymidine (stavudine bi-functional prodrugs with potent
More informationViral reproductive cycle
Lecture 29: Viruses Lecture outline 11/11/05 Types of viruses Bacteriophage Lytic and lysogenic life cycles viruses viruses Influenza Prions Mad cow disease 0.5 µm Figure 18.4 Viral structure of capsid
More informationAdditional methods appearing in the supplement are described in the Experimental Procedures section of the manuscript.
Supplemental Materials: I. Supplemental Methods II. Supplemental Figure Legends III. Supplemental Figures Supplemental Methods Cell Culture and Transfections for Wild Type and JNK1-/-,JNK2-/- MEFs: The
More informationInhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin
Inhibitors of Methionine Aminopeptidase-2 2 in the Treatment of Non-Hodgkin Hodgkin s s Lymphoma Targeted Cancer Therapies William Westlin, Ph.D. Vice President, Preclinical Research Discovery of Fumagillin
More informationIn-vitro assay for Cytotoxicity activity in ethonolic extract of fruit rind of Couropita Guianensis aubl
ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 169-176 http://www.ijcmas.com Original Research Article In-vitro assay for Cytotoxicity activity in ethonolic extract of fruit rind of Couropita Guianensis
More informationALN-HBV. Laura Sepp-Lorenzino November 11, Alnylam Pharmaceuticals, Inc.
ALN-HBV Laura Sepp-Lorenzino November 11, 2016 2016 Alnylam Pharmaceuticals, Inc. 1 N-Acetyl Galactosamine (GalNAc) sirna Conjugates Subcutaneous Investigational RNAi Therapeutics 5 -sense 5 -AS ASGPR
More informationA Substituted Tetrahydro-Tetrazolo-Pyrimidine Is a Specific and Novel Inhibitor of Hepatitis B Virus Surface Antigen Secretion
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Dec. 2007, p. 4427 4437 Vol. 51, No. 12 0066-4804/07/$08.00 0 doi:10.1128/aac.00541-07 Copyright 2007, American Society for Microbiology. All Rights Reserved. A Substituted
More informationThe Application of Cell-Based Impedance Technology in Drug Discovery
The Application of Cell-Based Impedance Technology in Drug Discovery Yama A. Abassi, PhD Sr. Director Cell Biology and Assay Development ACEA Biosciences ACEA Biosciences Founded in early Located in San
More informationPharmacological management of viruses in obese patients
Cubist Pharmaceuticals The Shape of Cures to Come Pharmacological management of viruses in obese patients Dr. Dimitar Tonev, Medical Director UKINORD 1 Disclosures } The author is a pharmaceutical physician
More informationContents The Cytokine System The Discovery of the Brain Immunomodulators
Contents 1 The Cytokine System... 1 1.1 Inducible Character of Cytokine Formation and Reception... 1 1.2 Locality of Cytokine Action... 2 1.3 Superfluity of Cytokine System... 2 1.4 Interrelationship and
More informationIt has been estimated that 90% of individuals
Famciclovir for Cutaneous Herpesvirus Infections: An Update and Review of New Single-Day Dosing Indications Manju Chacko, MD; Jeffrey M. Weinberg, MD Infections with herpes simplex virus (HSV) types 1
More informationResistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine
Journal of Antimicrobial Chemotherapy Advance Access published December 9, 2009 J Antimicrob Chemother doi:10.1093/jac/dkp422 esistance profile of the new nucleoside reverse transcriptase inhibitor apricitabine
More informationCHAPTER-2 DRUG AND POLYMER PROFILES
57 CHAPTER-2 DRUG AND POLYMER PROFILES 58 2.1 DRUG PROFILES 2.1.1 Lamivudine (3TC) 85 US FDA approval date: November 1995 Structural formula of lamivudine Physicochemical properties of lamivudine 1. Description
More informationAntiviral Therapy 2014; 19: (doi: /IMP2770)
Antiviral Therapy 2014; 19:687 692 (doi: 10.3851/IMP2770) Short communication Tenofovir alafenamide is not a substrate for renal organic anion transporters (ATs) and does not exhibit AT-dependent cytotoxicity
More informationSUPPLEMENTARY MATERIAL
SUPPLEMENTARY MATERIAL Acetone and methanol fruit extracts of Terminalia paniculata inhibit HIV-1 infection in vitro Ankita Durge a, Pratiksha Jadaun a, Ashish Wadhwani a, Ashish A. Chinchansure b, Madhukar
More informationOverview of methodology, tools and reagents for evaluating cell proliferation and invasion using multicellular tumor spheroids.
The Next Step in the Evolution of 3D Culture: Utilizing Extracellular Matrix to Enhance Multicellular Tumor Spheroid Models for Proliferation and Invasion Overview of methodology, tools and reagents for
More informationShort Duration DAA Therapy for Hepatitis C: How Short Can We Go?
Short Duration DAA Therapy for Hepatitis C: How Short Can We Go? Shyam Kottilil MD, Ph.D. Institute of Human Virology, University of Maryland, Baltimore, MD HEPDART Kona, HI Disclosures Received research
More informationSupporting Information
Supporting Information Discovery of Pentacyclic Triterpenes as Potential Entry Inhibitors of Influenza Viruses Maorong Yu*,,, Longlong Si,, Yufei Wang, Yiming Wu, Fei Yu,, Pingxuan Jiao, Yongying Shi,
More informationAre Immune Modulators Really Needed to Cure HBV infection?
Are Immune Modulators Really Needed to Cure HBV infection? Harry L.A. Janssen Francis Family Chair of Hepatology Director Toronto Centre for Liver Disease University Health Network University of Toronto,
More informationPharmacological determinants of long-term treatment success
Professor David Back Liverpool, UK Pharmacological determinants of long-term treatment success Pharmacological Issues with Antiretroviral Therapy Intrinsic potency Bioavailability Effect of food and other
More informationACS Med. Chem. Lett. ASAP. Celeste Alverez Current Literature 8/5/2017. Celeste Wipf Group
1 Evaluation of oxetan-3-ol, thietan-3-ol, and derivatives thereof as bioisosteres of the carboxylic acid functional group Lassalas, P.; Oukoloff, K.; Makani, V.; James, M.; Tran, V.; Yao, Y.; Huang, L.;
More informationBerberine Sensitizes Human Ovarian Cancer Cells to Cisplatin Through mir-93/ PTEN/Akt Signaling Pathway
Chen Accepted: et al.: February Berberine 24, Sensitizes 2015 Ovarian Cancer Cells to Cisplatin www.karger.com/cpb 956 1421-9778/15/0363-0956$39.50/0 Original Paper This is an Open Access article licensed
More informationAzithromycin may antagonize inhaled tobramycin when targeting P. aeruginosa in cystic fibrosis
Data Supplement Azithromycin may antagonize inhaled tobramycin when targeting P. aeruginosa in cystic fibrosis Jerry A. Nick 1, Samuel M. Moskowitz 2, James F. Chmiel 3, Anna V. Forssén 4, Sun Ho Kim 2,
More informationSupplemental Information. The Hedgehog Pathway Effector Smoothened. Exhibits Signaling Competency in the Absence. of Ciliary Accumulation
Chemistry & Biology, Volume 21 Supplemental Information The edgehog Pathway Effector Exhibits Signaling Competency in the Absence of Ciliary Accumulation Chih-Wei Fan, Baozhi Chen, Irene Franco, Jianming
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity For life science research only. Not for use in diagnostic procedures. Featured Study: Using the Time Resolving
More informationProfessor David Back
THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor David Back University of Liverpool 1-4 April 2014, Arena and Convention Centre Liverpool THIRD JOINT CONFERENCE OF BHIVA AND BASHH 2014 Professor
More informationOncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy
Oncolytic Adenovirus Complexes Coated with Lipids and Calcium Phosphate for Cancer Gene Therapy Jianhua Chen, Pei Gao, Sujing Yuan, Rongxin Li, Aimin Ni, Liang Chu, Li Ding, Ying Sun, Xin-Yuan Liu, Yourong
More informationSupplementary Figure S1
Supplementary Figure S1 12 1 8 6 4 2 1-3 1-2 1-1 1 1 1 1 2 1 3 PF-364422 (µm) U87 (EC 5 = 52.2 ± 8.8 µm) 12 1 8 6 4 2 1-4 1-3 1-2 1-1 1 1 1 1 2 CMPD1 (µm) Primary GM (EC 5 = 1.55 ±.3 µm) U138 (EC 5 = 1.7
More informationManagement of HBV infection between Specialist and General Practitioners
13 October 2016 Management of HBV infection between Specialist and General Practitioners Pietro Lampertico Gastroenterology and Hepatology Unit Fondazione IRCCS Cà Granda - Ospedale Maggiore Policlinico
More informationA Membrane Receptor Binding Assay Using MesoScale Electrochemiluminescence Technology
A Membrane Receptor Binding Assay Using MesoScale Electrochemiluminescence Technology Jian Huang, Jay Liu and Robert Bostwick Lead Discovery Department AstraZeneca Pharmaceuticals Background The receptor
More informationHorizon Scanning Technology Summary. Tenofovir disoproxil fumarate for hepatitis B. National Horizon Scanning Centre. April 2007
Horizon Scanning Technology Summary National Horizon Scanning Centre Tenofovir disoproxil fumarate for hepatitis B April 2007 This technology summary is based on information available at the time of research
More informationSupplementary Information
Supplementary Information Lymphatic endothelial cells support tumor growth in breast cancer Esak Lee a, Niranjan B. Pandey a, and Aleksander S. Popel a,b a Department of Biomedical Engineering, Johns Hopkins
More informationDiscovery of Potent, Highly Selective, Broad Spectrum Antivirals
Discovery of Potent, Highly Selective, Broad Spectrum Antivirals Fred Hutch/Merck Infectious Disease Summit May 10, 2018 Sam Lee, Ph.D. 1 Forward Looking Statements This presentation contains forward-looking
More informationMedChem 401~ Retroviridae. Retroviridae
MedChem 401~ Retroviridae Retroviruses plus-sense RNA genome (!8-10 kb) protein capsid lipid envelop envelope glycoproteins reverse transcriptase enzyme integrase enzyme protease enzyme Retroviridae The
More informationThe HBV capsid inhibitor AB-423 exhibits a dual mode of action and displays additive/synergistic effects in in vitro combination studies
The HBV capsid inhibitor AB-423 exhibits a dual mode of action and displays additive/synergistic effects in in vitro combination studies Rene Rijnbrand, PhD VP Biology Nagraj Mani, Andrew G. Cole, Andrzej
More informationNuclear Receptors Mediated Induction of P-glycoprotein by Antiretroviral Drugs in Human Brain Microvessel Endothelial Cells
Under The Microscope: The Impact of ARTs Nuclear Receptors Mediated Induction of P-glycoprotein by Antiretroviral Drugs in Human Brain Microvessel Endothelial Cells Gary N.Y. Chan, Ph. D. Candidate Supervisor:
More informationThe chemical name of acyclovir, USP is 2-amino-1,9-dihydro-9-[(2-hydroxyethoxy)methyl]-6Hpurin-6-one; it has the following structural formula:
Acyclovir Ointment, USP 5% DESCRIPTION Acyclovir, USP, is a synthetic nucleoside analogue active against herpes viruses. Acyclovir ointment, USP 5% is a formulation for topical administration. Each gram
More informationNovel Bispecific Antibodies for Treating Hepatitis B Virus Infection. Dr. Felix Bohne
Novel Bispecific Antibodies for Treating Hepatitis B Virus Infection Dr. Felix Bohne Munich, 11.05.2015 Consequences of Hepatitis B Virus 2 Global prevalence of Hepatitis B (percentage of population per
More informationConference Reports for NATAP. S/GSK Integrase Inhibitor Resistance Profile
Conference Reports for NATAP EACS - 12th European AIDS Conference November 11-14, 2009 Cologne, Germany Back S/GSK1349572 Integrase Inhibitor Resistance Profile Reported by Jules Levin EACS Oct 31-Nov
More informationA novel toxicogenomics-based approach to categorize. (non-)genotoxic carcinogens
Supplementary Material A novel toxicogenomics-based approach to categorize (non-)genotoxic carcinogens Mirjam M Schaap, Paul FK Wackers, Edwin P Zwart, Ilse Huijskens, Martijs J Jonker, Giel Hendriks,
More informationSusceptibility of Herpes Simplex Virus Isolated from Genital Herpes Lesions to ASP2151, A
AAC Accepts, published online ahead of print on 23 April 2012 Antimicrob. Agents Chemother. doi:10.1128/aac.00133-12 Copyright 2012, American Society for Microbiology. All Rights Reserved. 1 Susceptibility
More informationHepatitis C Cure The Invisible Epidemic
Hepatitis C Cure The Invisible Epidemic Iris House 8 Th Annual Face of AIDS Summit Hadiyah Charles Hepatitis Advocacy Manager Harm Reduction Coalition Hepatitis C Basics A virus that can cause chronic
More informationA Novel Recombinant Virus Reagent Products for Efficient Preparation Of Hepatitis B Animal Models
About FivePlus Beijing FivePlus Molecular Medicine Institute was established in 2005. The company has been dedicating itself to continuous innovation of viral vectors. The meaning of FivePlus is based
More informationHIV Remission: Compound screening and optimization. Michael D. Miller
HIV Remission: Compound screening and optimization Michael D. Miller Can we drive HIV into remission in large numbers of patients? "George Bernard Shaw, speaking as an Irishman, summed up an approach to
More informationEffects of AFP gene silencing on Survivin mrna expression inhibition in HepG2 cells
mrna expression inhibition in HepG2 cells Z.L. Fang 1, N. Fang 2, X.N. Han 3, G. Huang 2, X.J. Fu 2, G.S. Xie 2, N.R. Wang 2 and J.P. Xiong 1 1 Department of Medical Oncology, The First Affiliated Hospital
More informationHydroxyurea with ddi or ddi/d4t: a novel approach to HIV therapy
National AIDS Treatment Advocacy Project Hydroxyurea with ddi or ddi/d4t: a novel approach to HIV therapy Results from several hydroxyurea (ddi+hydroxyurea) studies were reported at Vancouver (July `96)
More informationDiscovery and Development of Anti-HBV Agents and Their Resistance
Molecules 2010, 15, 5878-5908; doi:10.3390/molecules15095878 Review OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Discovery and Development of Anti-HBV Agents and Their Resistance
More informationSpecific Targeting and Delivery of Therapeutics to Cancer Cells Based on the Tumor Microenvironment
Specific Targeting and Delivery of Therapeutics to Cancer Cells Based on the Tumor Microenvironment Damien Thévenin Department of Chemistry Bioscience in the 21st century (Sep. 14, 218) Anticancer Drugs
More informationPROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA
PROPOSAL FOR THE DEVELOPMENT OF AN INTERNATIONAL REFERENCE PREPARATION FOR HEPATITIS D VIRUS RNA SoGAT Clinical Diagnostics II 30 September / 1 October 2009, Istanbul Michael Chudy Julia Kreß C. Micha
More informationAPPENDIX II: Corneal Penetration and Median Effective Dose of Antiviral Agents
APPENDIX II: Corneal Penetration and Median Effective Dose of Antiviral Agents Median Effective Dose (ED50) The median effective dose is a statistically derived dose of drug expected to produce a certain
More informationVIRUSES AND CANCER Michael Lea
VIRUSES AND CANCER 2010 Michael Lea VIRAL ONCOLOGY - LECTURE OUTLINE 1. Historical Review 2. Viruses Associated with Cancer 3. RNA Tumor Viruses 4. DNA Tumor Viruses HISTORICAL REVIEW Historical Review
More informationNEW IHC A n t i b o d i e s
NEW IHC Antibodies TABLE OF CONTENTS NEW IHC ANTIBODIES from Cell Marque CITED1 (5H6).... 1 Claudin 7 (5D10F3).... 1 GATA1 (4F5).... 1 Transgelin (2A10C2).... 1 NEW IHC ANTIBODIES using RabMAb Technology
More informationNIH Public Access Author Manuscript Bioorg Med Chem Lett. Author manuscript; available in PMC 2013 June 15.
NIH Public Access Author Manuscript Published in final edited form as: Bioorg Med Chem Lett. 2012 June 15; 22(12): 4064 4067. doi:10.1016/j.bmcl.2012.04.078. Pre-steady state kinetic analysis of cyclobutyl
More informationHBV/HCV Eradication. Prof. Jean-Michel Pawlotsky, MD, PhD
HBV/HCV Eradication Prof. Jean-Michel Pawlotsky, MD, PhD National Reference Center for Viral Hepatitis B, C and delta Department of Virology & INSERM U955 Henri Mondor Hospital University of Paris-Est
More informationOriginal article Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytes
Original article Clevudine is efficiently phosphorylated to the active triphosphate form in primary human hepatocytes Congrong Niu, Eisuke Murakami and Phillip A Furman* Pharmasset, Inc., Princeton, NJ,
More informationBIOTARGET-1 SERUM-FREE MEDIUM
TECHNICAL INFORMATION BIOTARGET-1 SERUM-FREE MEDIUM Cat. No. 05-080-1 Introduction The BIOTARGET-1 formulation has been developed specifically for use with mononuclear cells (lymphocytes and monocytes)
More informationThe E138A substitution in HIV-1 reverse transcriptase decreases in vitro. susceptibility to emtricitabine as indicated by competitive fitness assays
AAC Accepts, published online ahead of print on 13 January 2014 Antimicrob. Agents Chemother. doi:10.1128/aac.02114-13 Copyright 2014, American Society for Microbiology. All Rights Reserved. 1 2 The E138A
More informationIs HCV drug resistance an issue?
Is HCV drug resistance an issue? 5TH ASIAN CONFERENCE ON HEPATITIS&AIDS NANJING, CHINA 28-29 MAY 2016 FROM BASIC SCIENCE TO CLINICAL PRACTIC Jürgen Kurt Rockstroh Department of Medicine I, University Hospital
More information6/9/2015. Eugene R. Schiff, MD, MACP, FRCP, MACG, AGAF, FAASLD Director, Schiff Center for Liver Diseases University of Miami
Grant/Research Support: AbbVie, BMS, Gilead, Merck, Orasure Technologies, Roche Molecular, Janssen, Discovery Life Sciences, Beckman Coulter, Inc., Siemens Corporation, MedMira Inc., Conatus Eugene R.
More informationInjectable Antiretrovirals The Promise and the Peril. Ian McGowan MD PhD FRCP University of Pittsburgh, PA, USA Cape Town, 6 th October, 2015
Injectable Antiretrovirals The Promise and the Peril Ian McGowan MD PhD FRCP University of Pittsburgh, PA, USA Cape Town, 6 th October, 2015 The Promise Long Acting Formulations Have been used to improve
More informationForward Looking Statements
Antiviral Therapies Forward Looking Statements This presentation contains forward-looking statements, including the timing of our drug development programs. Risks include delays in manufacturing created
More informationHepatitis B Virus infection: virology
Hepatitis B Virus infection: virology 167 Falk Symposium: Liver under constant attack from fat to viruses III Falk Gastro-Konferenz 17.-21. September 2008 Congress Centrum Mainz Maura Dandri Department
More informationPrediction of HBsAg Loss by Quantitative HBsAg Kinetics during Long-Term 2015
THAI J 16 GASTROENTEROL Treatment with Nucleos(t)ide Original Analogues Article Prediction of HBsAg Loss by Quantitative HBsAg Kinetics during Long-Term Treatment with Nucleos(t)ide Analogues Sombutsook
More informationA549 and A549-fLuc cells were maintained in high glucose Dulbecco modified
Cell culture and animal model A549 and A549-fLuc cells were maintained in high glucose Dulbecco modified Eagle medium supplemented with 10% fetal bovine serum at 37 C in humidified atmosphere containing
More informationSelected Properties of Daclatasvir
Selected Properties of Daclatasvir Other names Manufacturer Pharmacology / Mechanism of Action Activity Resistance Genotypic Daklinza, BMS-790052 Bristol-Myers Squibb Daclatasvir is a highly potent and
More informationChapter 1: Curcumin is excellent compound for various medicinal usages
Super-Curcumin Story Chapter 1: Curcumin is excellent compound for various medicinal usages Chapter 2: Discovery of Super-Curcumin analog Chapter 3: Anti-tumor activities of Super-Curcumin analog Chapter
More informationPearson r = P (one-tailed) = n = 9
8F4-Specific Lysis, % 1 UPN1 UPN3 8 UPN7 6 Pearson r =.69 UPN2 UPN5 P (one-tailed) =.192 4 UPN8 n = 9 2 UPN9 UPN4 UPN6 5 1 15 2 25 8 8F4, % Max MFI Supplementary Figure S1. AML samples UPN1-UPN9 show variable
More informationFocus Application. Compound-Induced Cytotoxicity
xcelligence System Real-Time Cell Analyzer Focus Application Compound-Induced Cytotoxicity Featured Study: Using the Time Resolving Function of the xcelligence System to Optimize Endpoint Viability and
More informationM (SAPPHIRE-II)
PRESS RELEASE AbbVie Demonstrates 96 percent SVR 12 in its Phase III Study of Treatment- Experienced Patients with Genotype 1 Hepatitis C Results further confirm phase II studies, with consistent virologic
More information7.012 Quiz 3 Answers
MIT Biology Department 7.012: Introductory Biology - Fall 2004 Instructors: Professor Eric Lander, Professor Robert A. Weinberg, Dr. Claudette Gardel Friday 11/12/04 7.012 Quiz 3 Answers A > 85 B 72-84
More informationSupplementary Figure 1. Establishment of prostacyclin-secreting hmscs. (a) PCR showed the integration of the COX-1-10aa-PGIS transgene into the
Supplementary Figure 1. Establishment of prostacyclin-secreting hmscs. (a) PCR showed the integration of the COX-1-10aa-PGIS transgene into the genomic DNA of hmscs (PGI2- hmscs). Native hmscs and plasmid
More informationMicrobiology Review Division of Antiviral Drug Products (HFD-530)
Microbiology Review Division of Antiviral Drug Products (HFD-530) NDA#: 21-785 Serial #: 000 Reviewer: N. Battula Date submitted: June 17,2004 Date received: June 18,2004 Date assigned: July 01,2004 Date
More informationStearoyl-CoA desaturase inhibition blocks formation of hepatitis C virus-induced specialized membranes
StearoyloA desaturase inhibition blocks formation of hepatitis virusinduced specialized membranes Rodney K. Lyn 1,2, Ragunath Singaravelu 1,3, Stacia Kargman 4, Shifawn Hara 1, Helen han 4, Renata balla
More information